Ms. Beena Goldenberg reports

ORGANIGRAM GLOBAL ANNOUNCES UPDATE TO CEO SUCCESSION PLAN

Beena Goldenberg will extend her tenure as chief executive officer of Organigram Global Inc. until Nov. 30, 2025, to support the completion of the company's continuing CEO search process.

The board's search has attracted strong interest and it is pleased with the progress as it focuses on identifying a leader aligned with Organigram's strategic vision and growth objectives. Ms. Goldenberg will continue to lead day-to-day operations, ensuring continuity of execution and momentum across all business lines. The company remains focused on delivering against its key priorities and creating long-term value for shareholders.

About Organigram Global Inc,

Organigram Global is a company (listed on the Nasdaq Global Select Market and Toronto Stock Exchange) whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Ltd., Organigram Global participates in the U.S. and Canadian cannabinoid beverages markets.

Organigram is focused on producing high-quality cannabis for adult recreational consumers as well as developing international business partnerships to extend the company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, Shred, Shred'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, Boxhot and Debunk. Organigram operates facilities in Moncton, N.B., and Lac-Superieur, Que., with a dedicated edibles manufacturing facility in Winnipeg, Man. The company also operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 (carbon dioxide) and hydrocarbon extraction capabilities and is optimized for formulation refinement, postprocessing of minor cannabinoids and preroll production. The facility in London will be optimized for labelling, packaging and national fulfilment. The company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

We seek Safe Harbor.